In Conversation

NIH's Carl Dieffenbach on the Long Road to a HIV Vaccine

NIH's Carl Dieffenbach on the Long Road to a HIV Vaccine

My goal has been to try to develop strategies and approaches that – when implemented at scale – could really have an impact on HIV incidence
Guy Jean Savoir – CEO, Carnot Laboratories

Guy Jean Savoir – CEO, Carnot Laboratories

The involvement of private entities has proven extremely beneficial, contributing to growth and market stability. However, despite these successes, there remains a widespread sentiment within the industry for greater transparency and organization in government dealings.  
Koji Ueda – Managing Director, Otsuka Pharmaceutical Hong Kong

Koji Ueda – Managing Director, Otsuka Pharmaceutical Hong Kong

CNS is a crucial portfolio segment for us, both globally and in Hong Kong. We can proudly say that we are one of the leading companies in the Hong Kong CNS market in terms of sales volume and market share  
Lionel Collet – President, Haute Autorité de Santé (HAS), France

Lionel Collet – President, Haute Autorité de Santé (HAS), France

Maintaining independence is paramount because we must never be beholden, in any way, to either industry interests or governmental influence.
Ahmad Hersi – CEO, King Saud University Medical City

Ahmad Hersi – CEO, King Saud University Medical City

These international collaborations are in alignment with the new vision set forth for KSUMC, which strives to rank among the top 10 universities and medical centers globally.
João Filipe Raposo – Clinical Director, APDP – Diabetes Portugal

João Filipe Raposo – Clinical Director, APDP – Diabetes Portugal

I am optimistic that diabetes care will improve. The inequality of care in Europe and Portugal exists, and it is really important to plan how we get the most innovative treatments to the most patients
Yu Wang – Chairman, Chinese Foundation for Hepatitis Prevention & Control

Yu Wang – Chairman, Chinese Foundation for Hepatitis Prevention & Control

The regulatory environment in China, guided by the NMPA, appears to be evolving positively, providing a conducive framework for pharmaceutical innovation and growth
Access to Medicine Foundation CEO on HIV Access Trends

Access to Medicine Foundation CEO on HIV Access Trends

We can't afford to have companies withdraw from infectious disease research—it's crucial for global health security
Sanjay Bhutani – Country Manager, Bausch & Lomb India

Sanjay Bhutani – Country Manager, Bausch & Lomb India

India is a market with great potential. However, it's important to recognize that the market is price-sensitive, requiring patience and a strategic approach
See more

In Case You Missed It

InFigures

The top 10 pharma companies in Portugal ranked by sales value in both the hospital and pharmacy markets. These charts are from IQVIA and are based on a moving annual total up to October 2023. Household Big Pharma names like Janssen (recently rebranded as Johnson & Johnson Innovative Medicines), Roche, MSD, and Novartis dominate the…

After the Hong Kong Exchanges and Clearing Limited’s (HKEX) 2018 move to allow pre-revenue biotech companies to raise capital in Hong Kong under its Chapter 18A mechanism, biotech listings surged with pre-clinical companies chosing to list on HKEX as a means of accessing global capital, raising around HKD 118 billion in funding. After a record…

Belgium, with a total of EUR 5.5 billion in R&D spending in 2021, is the country with the fourth largest research expenditure in the EU and the first per inhabitant.  As a recent study from Deloitte sponsored by the Belgian pharmaceutical industry association, pharma.be, shows, Belgium is also a leader in clinical trials, maintaining its…

The world’s top 10 medical technology companies for 2022 according to Medical Product Outsourcing (MPO). Abbott leads the way, followed by Medtronic, J&J, and Siemens Healthineers. Recent PharmaBoardroom interviews with some of these companies’ leading executives include Hugo F. Villegas, SVP & President, Canada & Latin America at Medtronic, Eman Ali, Regional Vice President for…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here